Loading ...
Sorry, an error occurred while loading the content.

Has anyone used these? MY vet gave them to Q-tip

Expand Messages
  • Cannon,Kimberly
    Azodyl Capsules Description: Azodyl is a breakthrough in veterinary product that helps to slow down uremic toxin buildup and prevent further kidney damage in
    Message 1 of 1 , Feb 21, 2007
    • 0 Attachment
      Azodyl Capsules
      Description:
      Azodyl is a breakthrough in veterinary product that helps to slow down
      uremic toxin buildup and prevent further kidney damage in dogs and cats by
      providing natural Enteric Dialysis through the use of beneficial bacteria
      that support kidney function.
      * The treatment choice at the first signs of azotemia in dog and cats
      with acute or chronic kidney disease.
      * Patented formula of naturally-occurring beneficial bacteria that
      metabolize and flush out uremic toxins that have diffused into the bowel as
      a result of increased toxin levels in the blood.
      * Easy-to-administer, enteric-coated capsules.
      * Can be used with other treatments and/or products, such as Epakitin.

      A common problem in companion animals
      Based on a survey conducted in 2005 among 109 U.S. veterinarians, chronic
      kidney disease affects, on average, 10.8% of cats and 5.2% of dogs brought
      in for consultation.1
      <<...OLE_Obj...>> The term "renal failure" refers to persistent
      azotemia accompanied by an inability to concentrate urine, usually resulting
      from a 75% loss of nephron function in both kidneys.
      <<...OLE_Obj...>> Kidney disease is a leading cause of death in dogs
      and cats.
      <<...OLE_Obj...>>

      An insidious process: The downward spiral of renal failure
      <<...OLE_Obj...>> Azotemia is defined as an increased concentration of
      non-protein nitrogenous compounds - usually urea and creatinine - in the
      blood, resulting from the kidneys' impaired ability to filter and eliminate
      waste.
      <<...OLE_Obj...>> Current medical management of renal failure consists
      of supportive and symptomatic therapy designed to address underlying
      conditions (if known).
      <<...OLE_Obj...>> Except for dialysis and kidney transplants, which
      are not common in veterinary medicine, nothing has been available to
      specifically focus on the reduction of toxin buildup in the blood... until
      now.
      <<...OLE_Obj...>>

      New hope for compromised kidneys through targeted use of beneficial bacteria
      Introducing Azodyl...
      <<...OLE_Obj...>> Breakthrough bacterial product for the reduction of
      azotemia in dogs and cats.
      <<...OLE_Obj...>> Patented formulation of naturally-occurring
      beneficial bacteria that metabolize and flush out uremic toxins that have
      diffused into the bowel.
      <<...OLE_Obj...>> Supports kidney function by providing natural
      Enteric Dialysis®. Slows down uremic toxin buildup in the blood and helps
      prevent further kidney damage.
      <<...OLE_Obj...>> Minimizes the clinical and biochemical consequences
      of reduced renal function.
      <<...OLE_Obj...>> The product of choice at the first signs of azotemia
      in cases of acute or chronic kidney disease.
      <<...OLE_Obj...>> A powerful combination for advanced renal
      support
      <<...OLE_Obj...>> Azodyl is the first veterinary
      product to specifically focus on the reduction of azotemia. * Ideally suited
      for use in IRIS stages II to IV.
      <<...OLE_Obj...>> While Epakitin(tm) has been shown to
      contribute to lower urea concentrations, its strength lies in its ability to
      reduce serum phosphorous levels.
      <<...OLE_Obj...>> Used together, Azodyl and Epakitin
      help reduce azotemia and phosphatemia. * Minimizing consequences of renal
      failure * Improving prognosis * Enhancing quality of life
      <<...OLE_Obj...>> Azodyl can safely be used with other
      conventional renal failure treatments, according to symptoms.

      Promising results: Azodyl reduces azotemia in minipigs1
      <<...OLE_Obj...>>
      Conclusion: Azodyl administered orally on a daily basis has the potential to
      decrease BUN levels and prolong survival in renal insuficiency.
      Study involved six 5/6th nephrectomized (equivalent to approximately 85%
      loss of kidney function) minipigs with moderate azotemia (mean = 104.2 ±
      40.0 mg/dL), four weeks post-nephrectomy. 2-4 weeks after the beginning of
      the study: - Placebo group = significant increase (p = 0.009) in mean BUN
      (to 150 ± 0 mg/dL) when compared to the Azodyl group - Azodyl group =
      decrease in BUN (to 75.1 ± 37.9 mg/dL) 8 weeks after the beginning of the
      study: - Placebo group = all minipigs died - Azodyl group = significant
      decrease (p=0.0016) in BUN (to 45.0 ± 5.0 mg/dL)
      Promising results: Preliminary clinical evaluation of Azodyl on feline
      azotemia2
      <<...OLE_Obj...>>
      Conclusion: Azodyl administered orally on a daily basis has the potential to
      decrease BUN and creatinine levels, and has a place in the management of
      chronic kidney disease in cats.
      Study involved seven cats presented to the author's clinic with elevated BUN
      (41 to 74 mg/dL) and serum creatinine (2.6 to 7.9 mg/dL). All cats received
      Azodyl for a period of 60 days. Results at Day 60 indicate a decrease in BUN
      in all cats and a reduction in creatinine levels in six out of seven (86%)
      patients treated with Azodyl, even though dosing was less than the
      recommended amount in most cats. Reductions in serum BUN and creatinine
      levels were also observed at Day 30.
      Directions Note: Capsules should be given whole and not opened or crushed.

      Morning Evening
      Under 5 lbs 1 0
      5 to 10 lbs 1 1
      Over 10 lbs 2 1
    Your message has been successfully submitted and would be delivered to recipients shortly.